A nurse is assessing a 58-year-old patient with stage 4 chronic kidney disease (CKD). Which assessment finding would be the MOST concerning and require immediate intervention?
1Serum phosphorus of 8.2 mg/dL with muscle twitching and Chvostek's sign✓ 정답
2Blood pressure of 158/94 mmHg with mild headache and dizziness
3Hemoglobin of 9.8 g/dL with fatigue and pale conjunctiva
4Serum creatinine of 4.5 mg/dL with decreased urine output and edema
해설
Hyperphosphatemia with neuromuscular irritability (muscle twitching, positive Chvostek's sign) indicates severe electrolyte imbalance requiring immediate intervention to prevent seizures or cardiac complications. Other options represent CKD complications manageable with routine monitoring and care.
The most concerning finding requiring immediate intervention is the serum potassium level of 6.8 mEq/L with peaked T waves on ECG. In the context of stage 4 chronic kidney disease (CKD), this represents a critical, life-threatening electrolyte disturbance that demands emergent treatment to prevent cardiac arrest.
Pathophysiology and Clinical Rationale
The normal range for serum potassium is typically 3.5 to 5.0 mEq/L. A level of 6.8 mEq/L constitutes severe hyperkalemia. In patients with CKD, the kidneys' ability to excrete potassium is significantly impaired, creating a constant risk for accumulation. The presence of peaked T waves on the ECG is a classic and ominous sign, indicating that the elevated potassium is already altering cardiac myocyte electrophysiology. This alteration destabilizes the resting membrane potential, initially making cells more excitable (manifesting as peaked T waves) before progressing to a dangerous reduction in excitability [1].
This scenario is a hallmark of a potentially fatal positive feedback loop. The combination of Hyperkalemia and Renal failure can synergistically depress cardiac conduction, leading to severe bradycardia and hemodynamic instability [3]. The ECG changes are not merely a diagnostic clue but a direct signal of impending cardiac emergency. If uncorrected, the conduction disturbance can rapidly progress from peaked T waves to loss of P waves, widening of the QRS complex, and ultimately a sine-wave pattern, ventricular fibrillation, or complete atrioventricular (AV) block with a slow ventricular escape rhythm, as seen in cases of severe hyperkalemia [1]. The risk is heightened if the patient is concurrently taking AV nodal-blocking agents, which can trigger the life-threatening BRASH syndrome (Bradycardia, Renal failure, AV blockade, Shock, Hyperkalemia), creating a vicious cycle of worsening bradycardia and renal dysfunction that is refractory to standard treatments [2][4].
Analysis of Other Findings
While the other options represent significant complications of CKD that require management, they do not pose the same immediate threat of death within minutes as severe hyperkalemia with ECG changes.
- Blood pressure of 168/94 mmHg: This indicates stage 2 hypertension, a common and serious comorbidity in CKD that accelerates renal damage and increases cardiovascular risk. Management typically involves medication adjustment and monitoring, but it is not an immediate, minute-to-minute emergency like a malignant dysrhythmia.
- Hemoglobin of 9.2 g/dL with fatigue: This reflects the anemia of CKD, caused by deficient erythropoietin production. While profoundly impactful on quality of life and cardiac workload, it is a chronic condition managed with iron supplementation and erythropoiesis-stimulating agents. It does not require emergent intervention.
- Serum phosphorus of 6.5 mg/dL with mild bone pain: This hyperphosphatemia is a key driver of secondary hyperparathyroidism and renal osteodystrophy in CKD. Management with phosphate binders and dietary restriction is crucial for long-term bone and cardiovascular health, but it is not an acute, life-threatening finding.
The nurse's priority is to recognize that the combination of a critically high potassium level and corresponding ECG changes signals an immediate risk for fatal cardiac arrhythmias, necessitating urgent notification of the healthcare provider and preparation for emergency interventions such as intravenous calcium to stabilize the myocardium, followed by therapies to shift potassium intracellularly and remove it from the body [1][3].
References (research sources)
[1]
Complete Atrioventricular Block Due to Severe Hyperkalemia in a Hemodialysis Patient: Successful Management with Temporary Transvenous Pacing.Research articleAbdi AE, Arın CB, Abdi IA, Ahmed SA, Dahir OF, Aden AS, Hassan MO. (2026) · DOI: 10.2147/imcrj.s596948
[2]
BRASH Syndrome.Research articleIyow SN, Adam AM, Adan HAA, Sağdıç A, Mohamed AY. (2026) · DOI: 10.1002/ccr3.72833
[3]
Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome: A Deadly Pentad of Symptoms.Research articleKillian P, Espinosa J, Lucerna A. (2026) · DOI: 10.7759/cureus.106824
[4]
Unmasking BRASH Syndrome: A Clinical Challenge in Bradycardia and Renal Dysfunction.Research articleZuhri E, Erriyanti S. (2025) · DOI: 10.7759/cureus.98773
Clinical Priority in CKD Electrolyte Crisis: In stage 4 CKD, the most immediate life-threatening emergency is symptomatic hypocalcemia secondary to severe hyperphosphatemia. The presence of neuromuscular irritability (muscle twitching, positive Chvostek's sign) indicates a risk for progression to laryngospasm, seizures, or cardiac arrhythmias.
Immediate Nursing Actions
Airway and Cardiac Monitoring: Place the patient on continuous cardiac telemetry to monitor for prolonged QT interval or arrhythmias. Assess respiratory status frequently for stridor or signs of laryngospasm. Keep emergency airway equipment and IV calcium gluconate readily available at the bedside.
Seizure Precautions: Initiate seizure precautions, including padding side rails, ensuring suction equipment is functional, and keeping the bed in the lowest position.
Medication Administration: Anticipate an order for intravenous calcium gluconate or calcium chloride to rapidly correct severe hypocalcemia. This is the definitive emergency intervention to stabilize cardiac and neuronal membranes.
Ongoing Management and Education
Phosphate Binders: Administer prescribed phosphate binders (e.g., sevelamer, calcium acetate) with meals to reduce intestinal phosphorus absorption. Educate the patient on strict adherence to timing—taking the binder exactly when eating.
Dietary Counseling: Reinforce a low-phosphorus diet, advising the patient to avoid high-phosphorus foods such as dairy products, dark colas, processed meats, and packaged foods with phosphate additives.
Safety and Fall Prevention: Due to muscle weakness and potential tetany, implement fall precautions. Advise the patient to request assistance with ambulation and to rise slowly from a lying or sitting position.
Key Distinction for NCLEX: While hypertension, anemia, and elevated creatinine are expected and serious manifestations of CKD, they represent chronic management challenges. The combination of severe hyperphosphatemia and clinical tetany signals an acute electrolyte crisis that takes priority over other abnormal findings.
Chvostek's Sign — Facial muscle contraction elicited by tapping the facial nerve anterior to the ear, indicating neuromuscular irritability due to hypocalcemia.
Hypocalcemic Tetany — A state of increased neuromuscular excitability caused by low ionized calcium, manifesting as muscle twitching, spasms, and potentially laryngospasm or seizures.
Hyperphosphatemia in CKD — Elevated serum phosphorus due to reduced renal excretion, which binds calcium and lowers biologically active calcium levels, contributing to secondary hyperparathyroidism.
CKD-MBD — Chronic Kidney Disease-Mineral and Bone Disorder, a systemic syndrome encompassing abnormalities in calcium, phosphorus, PTH, and vitamin D metabolism, along with bone disease and vascular calcification.